Smith & Nephew (SNN) Tax Provisions (2009 - 2024)
Smith & Nephew (SNN) posted quarterly Tax Provisions of $86.0 million for Q4 2024, up 320.51% year-on-year from $20.5 million in Q1 2024, and up 320.51% on a QoQ basis from -$39.0 million in Q4 2023.
Smith & Nephew (SNN) Tax Provisions (2009 - 2024) Analysis & Trends
Smith & Nephew (SNN) has reported Tax Provisions for 16 consecutive years, with $86.0 million the latest figure, recorded in Q4 2024.
- Quarterly Tax Provisions rose 320.51% year-over-year to $86.0 million in Q4 2024, while the trailing twelve-month figure through Dec 2024 was $2.0 million (down 96.0% YoY) and the FY2025 annual result came in at $154.0 million, up 79.07% from the prior year.
- Tax Provisions improved to $86.0 million in Q4 2024 per SNN's latest filing, from -$39.0 million in the prior quarter.
- Over the last five years, Tax Provisions for SNN reached as high as $134.0 million in Q4 2020 and fell as low as -$39.0 million in Q4 2023.
- A 5-year average of $27.2 million and a median of -$18.0 million in 2021 frame the typical range for Tax Provisions.
- Annual changes were most pronounced in 2021 — Tax Provisions plunged 113.43% — and 2024, when it surged 320.51%.
- Year by year, Tax Provisions stood at $134.0 million in 2020, then slumped by 113.43% to -$18.0 million in 2021, then tumbled by 50.0% to -$27.0 million in 2022, then slumped by 44.44% to -$39.0 million in 2023, then jumped by 320.51% to $86.0 million in 2024.
- According to Business Quant data, Tax Provisions over the past three periods registered $86.0 million, -$39.0 million, and -$27.0 million for Q4 2024, Q4 2023, and Q4 2022 respectively.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Taxes (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 201.40 Bn | 194.75 Bn | 6.27 Bn | 372.00 Mn |
| 2 | Stryker | 122.29 Bn | 119.41 Bn | 3.81 Bn | 105.00 Mn |
| 3 | Medtronic | 105.01 Bn | 96.40 Bn | 6.41 Bn | 575.00 Mn |
| 4 | Boston Scientific | 64.81 Bn | 63.59 Bn | 3.61 Bn | -176.00 Mn |
| 5 | Edwards Lifesciences | 55.28 Bn | 51.60 Bn | 1.29 Bn | 78.30 Mn |
| 6 | Dexcom | 29.06 Bn | 27.94 Bn | 750.30 Mn | 70.00 Mn |
| 7 | Koninklijke Philips | 29.02 Bn | 25.93 Bn | 2.07 Bn | -51.51 Mn |
| 8 | GE HealthCare Technologies | 28.27 Bn | 26.20 Bn | 1.98 Bn | 94.00 Mn |
| 9 | Smith & Nephew | 25.80 Bn | 25.22 Bn | - | - |
| 10 | Steris | 20.59 Bn | 20.16 Bn | 697.10 Mn | 84.20 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2024 | 86.00 Mn |
| Dec 31, 2023 | -39.00 Mn |
| Dec 31, 2022 | -27.00 Mn |
| Dec 31, 2021 | -18.00 Mn |
| Dec 31, 2020 | 134.00 Mn |
| Dec 31, 2019 | -143.00 Mn |
| Dec 31, 2018 | -118.00 Mn |
| Dec 31, 2017 | -112.00 Mn |
| Dec 31, 2016 | -278.00 Mn |
| Dec 31, 2015 | -149.00 Mn |
| Dec 31, 2014 | -213.00 Mn |
| Sep 30, 2014 | -51.00 Mn |
| Mar 31, 2014 | -52.00 Mn |
| Dec 31, 2013 | -246.00 Mn |
| Mar 31, 2013 | -70.00 Mn |
| Dec 31, 2012 | -371.00 Mn |
| Jun 30, 2012 | -166.00 Mn |
| Mar 31, 2012 | -73.00 Mn |
| Dec 31, 2011 | -266.00 Mn |
| Sep 30, 2011 | -196.00 Mn |